Paeoniflorin inhibits cell growth and induces cell cycle arrest through inhibition of FoxM1 in colorectal cancer cells

References

• Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30. PMID:28055103
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177–193. PMID:28248415
   PubMed Web of Science ®Google Scholar
• Stintzing S, Tejpar S, Gibbs P, et al. Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes. Eur J Cancer. 2017;84:69–80. doi:10.1016/j.ejca.2017.07.016. PMID:28787661
   PubMed Web of Science ®Google Scholar
• Gartel AL. FOXM1 in cancer: interactions and vulnerabilities. Cancer Res. 2017;77:3135–3139. doi:10.1158/0008-5472.CAN-16-3566. PMID:28584182
   PubMed Web of Science ®Google Scholar
• Bella L, Zona S, Nestal de Moraes G, et al. FOXM1: A key oncofoetal transcription factor in health and disease. Semin Cancer Biol. 2014;29:32–39. doi:10.1016/j.semcancer.2014.07.008. PMID:25068996
   PubMed Web of Science ®Google Scholar
• Laoukili J, Stahl M, Medema RH. FoxM1: at the crossroads of ageing and cancer. Biochim Biophys Acta. 2007;1775:92–102. PMID:17014965
   PubMed Web of Science ®Google Scholar
• Wierstra I, Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol Chem. 2007;388:1257–1274. doi:10.1515/BC.2007.159. PMID:18020943
   PubMed Web of Science ®Google Scholar
• Huang C, Du J, Xie K. FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis. Biochim Biophys Acta. 2014;1845:104–116. PMID:24418574
   PubMed Web of Science ®Google Scholar
• Li L, Wu D, Yu Q, et al. Prognostic value of FOXM1 in solid tumors: a systematic review and meta-analysis. Oncotarget. 2017;8:32298–32308. PMID:28427178
   PubMedGoogle Scholar
• Quan M, Wang P, Cui J, et al. The roles of FOXM1 in pancreatic stem cells and carcinogenesis. Mol Cancer. 2013;12:159. doi:10.1186/1476-4598-12-159. PMID:24325450
   PubMed Web of Science ®Google Scholar
• Wierstra I. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy. Adv Cancer Res. 2013;119:191–419. doi:10.1016/B978-0-12-407190-2.00016-2. PMID:23870513
   PubMed Web of Science ®Google Scholar
• Shi M, Cui J, Xie K. Signaling of miRNAs-FOXM1 in cancer and potential targeted therapy. Curr Drug Targets. 2013;14:1192–1202. doi:10.2174/13894501113149990192. PMID:23834153
   PubMed Web of Science ®Google Scholar
• Wierstra I. The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles. Adv Cancer Res. 2013;118:97–398. doi:10.1016/B978-0-12-407173-5.00004-2. PMID:23768511
   PubMed Web of Science ®Google Scholar
• Halasi M, Gartel AL. Targeting FOXM1 in cancer. Biochem Pharmacol. 2013;85:644–652. doi:10.1016/j.bcp.2012.10.013. PMID:23103567
   PubMed Web of Science ®Google Scholar
• Chen A, Wang H, Zhang Y, et al. Paeoniflorin exerts neuroprotective effects against glutamateinduced PC12 cellular cytotoxicity by inhibiting apoptosis. Int J Mol Med. 2017;40:825–833. PMID:28731183
   PubMed Web of Science ®Google Scholar
• Gu P, Zhu L, Liu Y, et al. Protective effects of paeoniflorin on TNBS-induced ulcerative colitis through inhibiting NF-kappaB pathway and apoptosis in mice. Int Immunopharmacol. 2017;50:152–160. doi:10.1016/j.intimp.2017.06.022. PMID:28666238
   PubMed Web of Science ®Google Scholar
• Hao J, Yang X, Ding XL, et al. Paeoniflorin potentiates the inhibitory effects of erlotinib in pancreatic cancer cell lines by reducing ErbB3 phosphorylation. Sci Rep. 2016;6:32809. doi:10.1038/srep32809. PMID:27609096
   PubMed Web of Science ®Google Scholar
• Yang N, Cui H, Han F, et al. Paeoniflorin inhibits human pancreatic cancer cell apoptosis via suppression of MMP-9 and ERK signaling. Oncol Lett. 2016;12:1471–1476. PMID:27446455
   PubMed Web of Science ®Google Scholar
• Wang S, Liu W. Paeoniflorin inhibits proliferation and promotes apoptosis of multiple myeloma cells via its effects on microRNA29b and matrix metalloproteinase2. Mol Med Rep. 2016;14:2143–2149. doi:10.3892/mmr.2016.5498. PMID:27430753
   PubMed Web of Science ®Google Scholar
• Li Y, Gong L, Qi R, et al. Paeoniflorin suppresses pancreatic cancer cell growth by upregulating HTRA3 expression. Drug Des Devel Ther. 2017;11:2481–2491. doi:10.2147/DDDT.S134518. PMID:28860718
   PubMed Web of Science ®Google Scholar
• Zhang Q, Yuan Y, Cui J, et al. Paeoniflorin inhibits proliferation and invasion of breast cancer cells through suppressing Notch-1 signaling pathway. Biomed Pharmacother. 2016;78:197–203. doi:10.1016/j.biopha.2016.01.019. PMID:26898442
   PubMed Web of Science ®Google Scholar
• Zhong S, Zhou A, Qi F, et al. Downregulating forkhead box M1 inhibits proliferation by inhibiting autophagy in the sw480 cell line. Biomed Rep. 2017;7:47–50. doi:10.3892/br.2017.915. PMID:28685059
   PubMed Web of Science ®Google Scholar
• Song IS, Jeong YJ, Jeong SH, et al. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function. Gastroenterology. 2015;149:1006–1016 e9. doi:10.1053/j.gastro.2015.06.007. PMID:26091938
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang K, Zhou L, et al. Expression and potential correlation among Forkhead box protein M1, Caveolin-1 and E-cadherin in colorectal cancer. Oncol Lett. 2016;12:2381–2388. PMID:27698803
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang Y, Feng Y, et al. Gli1 promotes colorectal cancer metastasis in a Foxm1-dependent manner by activating EMT and PI3K-AKT signaling. Oncotarget. 2016;7:86134–86147. PMID:27863385
   PubMedGoogle Scholar
• Valverde A, Penarando J, Canas A, et al. The addition of celecoxib improves the antitumor effect of cetuximab in colorectal cancer: role of EGFR-RAS-FOXM1-beta- catenin signaling axis. Oncotarget. 2017;8:21754–21769. PMID:28423516
   PubMed Web of Science ®Google Scholar
• Wang D, Hu G, Du Y, et al. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells. J Exp Clin Cancer Res. 2017;36:23. doi:10.1186/s13046-017-0491-7. PMID:28148279
   PubMed Web of Science ®Google Scholar
• Xie T, Geng J, Wang Y, et al. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10. Oncotarget. 2017;8:8574–8589. PMID:28051999
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Wang IC, Yoder HM, et al. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer. Gastroenterology. 2007;132:1420–1431. doi:10.1053/j.gastro.2007.01.036. PMID:17408638
   PubMed Web of Science ®Google Scholar
• Li D, Wei P, Peng Z, et al. The critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis. Clin Cancer Res. 2013;19:62–72. doi:10.1158/1078-0432.CCR-12-1588. PMID:23136192
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhong H, Li L, et al. Overexpressed transcription factor FOXM1 contributes to the progression of colorectal cancer. Mol Med Rep. 2016;13:2696–2700. doi:10.3892/mmr.2016.4875. PMID:26861549
   PubMed Web of Science ®Google Scholar
• Zhang HG, Xu XW, Shi XP, et al. Overexpression of forkhead box protein M1 (FOXM1) plays a critical role in colorectal cancer. Clin Transl Oncol. 2016;18:527–532. doi:10.1007/s12094-015-1400-1. PMID:26370421
   PubMed Web of Science ®Google Scholar
• Chu XY, Zhu ZM, Chen LB, et al. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer. Acta Histochem. 2012;114:755–762. doi:10.1016/j.acthis.2012.01.002. PMID:22326401
   PubMed Web of Science ®Google Scholar
• Yang K, Jiang L, Hu Y, et al. Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation. J Exp Clin Cancer Res. 2015;34:40. doi:10.1186/s13046-015-0158-1. PMID:25935853
   PubMed Web of Science ®Google Scholar
• Zheng Y, Guo J, Zhou J, et al. FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasion. BMC Med Genomics. 2015;8:49. doi:10.1186/s12920-015-0126-9. PMID:26264222
   PubMed Web of Science ®Google Scholar
• Luo X, Yao J, Nie P, et al. FOXM1 promotes invasion and migration of colorectal cancer cells partially dependent on HSPA5 transactivation. Oncotarget. 2016;7:26480–26495. doi:10.18632/oncotarget.8419. PMID:27034162
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang L, Du Y, et al. A novel FOXM1 isoform, FOXM1D, promotes epithelial-mesenchymal transition and metastasis through ROCKs activation in colorectal cancer. Oncogene. 2017;36:807–819. doi:10.1038/onc.2016.249. PMID:27399334
   PubMed Web of Science ®Google Scholar
• Wan LY, Deng J, Xiang XJ, et al. miR-320 enhances the sensitivity of human colon cancer cells to chemoradiotherapy in vitro by targeting FOXM1. Biochem Biophys Res Commun. 2015;457:125–132. doi:10.1016/j.bbrc.2014.11.039. PMID:25446103
   PubMed Web of Science ®Google Scholar
• Vishnubalaji R, Hamam R, Yue S, et al. MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1. Oncotarget. 2016;7:35789–35802. doi:10.18632/oncotarget.8937. PMID:27119506
   PubMedGoogle Scholar
• Xu K, Liu X, Mao X, et al. MicroRNA-149 suppresses colorectal cancer cell migration and invasion by directly targeting forkhead box transcription factor FOXM1. Cell Physiol Biochem. 2015;35:499–515. doi:10.1159/000369715. PMID:25613903
   PubMed Web of Science ®Google Scholar
• Liu X, Xie T, Mao X, et al. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1. Cell Physiol Biochem. 2016;39:617–629. doi:10.1159/000445653. PMID:27415661
   PubMed Web of Science ®Google Scholar
• Hung JY, Yang CJ, Tsai YM, et al. Antiproliferative activity of paeoniflorin is through cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway in human non-small cell lung cancer A549 cells. Clin Exp Pharmacol Physiol. 2008;35:141–147. doi:10.1111/j.1440-1681.2008.04935.x. PMID:17941899
   PubMed Web of Science ®Google Scholar
• Wu H, Li W, Wang T, et al. Paeoniflorin suppress NF-kappaB activation through modulation of I kappaB alpha and enhances 5-fluorouracil-induced apoptosis in human gastric carcinoma cells. Biomed Pharmacother. 2008;62:659–666. doi:10.1016/j.biopha.2008.08.002. PMID:18809274
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang S. Modulating Bcl-2 family proteins and caspase-3 in induction of apoptosis by paeoniflorin in human cervical cancer cells. Phytother Res. 2011;25:1551–1557. doi:10.1002/ptr.3534. PMID:21698669
   PubMed Web of Science ®Google Scholar
• Hu S, Sun W, Wei W, et al. Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis. Anticancer Drugs. 2013;24:140–149. doi:10.1097/CAD.0b013e32835a4dac. PMID:23069790
   PubMed Web of Science ®Google Scholar
• Wang H, Zhou H, Wang CX, et al. Paeoniflorin inhibits growth of human colorectal carcinoma HT 29 cells in vitro and in vivo. Food Chem Toxicol. 2012;50:1560–1567. doi:10.1016/j.fct.2012.01.035. PMID:22326807
   PubMed Web of Science ®Google Scholar
• Lu JT, He W, Song SS, et al. Paeoniflorin inhibited the tumor invasion and metastasis in human hepatocellular carcinoma cells. Bratisl Lek Listy. 2014;115:427–433. PMID:25077366
   PubMed Web of Science ®Google Scholar
• Fang S, Zhu W, Zhang Y, et al. Paeoniflorin modulates multidrug resistance of a human gastric cancer cell line via the inhibition of NF-kappaB activation. Mol Med Rep. 2012;5:351–356. PMID:22051979
   PubMed Web of Science ®Google Scholar
• Nie XH, Ou-yang J, Xing Y, et al. Paeoniflorin inhibits human glioma cells via STAT3 degradation by the ubiquitin-proteasome pathway. Drug Des Devel Ther. 2015;9:5611–5622. PMID:26508835
   PubMed Web of Science ®Google Scholar
• Zhou Z, Wang S, Song C, et al. Paeoniflorin prevents hypoxia-induced epithelial-mesenchymal transition in human breast cancer cells. OncoTargets and therapy. 2016;9:2511–2518. doi:10.2147/OTT.S102422. PMID:27175085
   PubMed Web of Science ®Google Scholar
• Zheng YB, Xiao GC, Tong SL, et al. Paeoniflorin inhibits human gastric carcinoma cell proliferation through up-regulation of microRNA-124 and suppression of PI3K/Akt and STAT3 signaling. World J Gastroenterol. 2015;21:7197–7207. doi:10.3748/wjg.v21.i23.7197. PMID:26109806
   PubMed Web of Science ®Google Scholar
• Petrovic V, Costa RH, Lau LF, et al. Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin. Cancer biology & therapy. 2010;9:1008–1016. doi:10.4161/cbt.9.12.11710.
   PubMed Web of Science ®Google Scholar
• Jin H, Li XJ, Park MH, et al. FOXM1-mediated downregulation of uPA and MMP9 by 3,3'-diindolylmethane inhibits migration and invasion of human colorectal cancer cells. Oncol Rep. 2015;33:3171–3177. doi:10.3892/or.2015.3938. PMID:25962429
   PubMed Web of Science ®Google Scholar
• Yin X, Zhang Y, Su J, et al. Rottlerin exerts its anti-tumor activity through inhibition of Skp2 in breast cancer cells. Oncotarget. 2016;7:66512–66524. doi:10.18632/oncotarget.11614. PMID:27582552
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhao M, Xu H, et al. RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis. Oncotarget. 2014;5:6734–6745. doi:10.18632/oncotarget.2244. PMID:25216515
   PubMed Web of Science ®Google Scholar
• Wang L, Hou Y, Yin X, et al. Rottlerin inhibits cell growth and invasion via down-regulation of Cdc20 in glioma cells. Oncotarget. 2016;7:69770–69782. PMID:27626499
   PubMed Web of Science ®Google Scholar